Theme: Recent Advancements and Complications in the field of Diabetes and Endocrinology

WORLD DIABETES 2024

Renowned Speakers

WORLD DIABETES 2024

Conference Series warmly welcomes you to the “26th World Congress on Diabetes and Endocrine Disorders which will be held on October 24-25, 2024 in London, UK” with the theme Recent Advancements and Complications in the Field of Diabetes and Endocrinology. The wide range of topics will give attendees a chance to learn about every aspect of Diabetes and Endocrinology. The Delegates will be able to learn about the latest upgrades and exchange experiences with internationally renowned speakers at this gathering. All participants who are interested in contributing their research and data in the field of Diabetes and Endocrinology are invited.

World Diabetes 2024 unites the worldwide pioneers who are involved in the Diabetes and Endocrinology field to explore their research work at the conference. Our Conference provides a great chance to collaborate with global business delegates and researchers and it is all set to be adorned by world renowned speakers. It's a unique stage for analysts to comprehend how it causes. What are the things to work out for the end of this issue?

The “26th World Congress on Diabetes and Endocrine Disorders will take place from October 24-25, 2024, in London, UK following the theme Recent Advancements and Complications in the field of Diabetes and Endocrinology. It encompasses a wide range of activities, including lectures, oral and poster presentations, exhibitions, panel discussions, and a wealth of knowledge sharing opportunities. This year's agenda offers you the chance to take part in or organize a Workshop in addition to innovative presentations and discussions.

World Diabetes 2024 is available in both in-person and online formats. We feel that your choice will allow for widespread engagement.

The major goal of World Diabetes 2024 is to bring together Diabetologists, Endocrinologists, renowned speakers, professors, scientists, educationalists, researchers, and students to exchange ideas and expertise across disciplines to facilitate interdisciplinary cooperation in research and clinical settings and to provide them with a forum on which to exchange knowledge and discuss recent developments in the field of Diabetes and Endocrinology. The new forms of innovations and research are encouraged and provide an opportunity to the people who are attending the conference. It allows delegates to have issues addressed on Diabetes and Endocrine Disorders by recognized specialists who are up to date with the latest developments in the respective field and provide information on new techniques and technologies. You can share your research findings and gain recognition through certificates awarded by our esteemed world-class organizing committee.

Featured in World Diabetes 2024:

  • Workshop
  • Keynote & Plenary sessions
  • Young researcher’s forum
  • Symposium
  • Exhibitor booths
  • Separate room for B2B meetings
  • Research excellence award
  • Best poster competition
  • Young Scientist Award

Abstract Submission:

Speakers from all over the world can submit their abstracts, research papers, case studies, and posters by choosing a topic from the “Call for Abstract” or your area of research interest. For attendees, Doctors, Presenters, Physicians, Scientists, Educationalists, Students, Academicians, Sponsors, Exhibitors, and Groups, World Diabetes 2024 offers hotel packages and affordable registration and also provides Special registration for Webinar. Anyone can register for this conference using the choices available on the registration page

Abstract Submission URL: https://worlddiabetes.conferenceseries.com/abstract-submission.php

Abstract Submission Guidelines:

Ø  Abstract length must not exceed 300 words.

Ø  The title should be in sentence case.

Ø  Mention the full name of the author and co-authors (if any) along with affiliation.

Ø  It should contain a short biography of the author (limited to 100 words) along with the photograph.

Ø All the abstracts will be reviewed by the scientific committee members and you will get an email within 24-48 hours after submission of your abstract.

Ø All the accepted abstracts will be published in the conference proceedings in the respective Journal.

World Diabetes 2024 will be an excellent arena for debating novel discoveries and concepts. Attendees' curiosity in the field of Diabetes and Endocrine Disorders will be piqued by the two-day session. This conference offers networking opportunities for Diabetologists, Endocrinologists, Specialists, renowned speakers, professors, scientists, educationalists, researchers, students, and members of all Diabetes and Endocrinology associations and universities. It also makes it easier to access possibilities for ongoing education and top-notch content delivered by keynote speakers.

Registration Details URL: https://worlddiabetes.conferenceseries.com/registration.php

This is your best chance to get in front of the biggest group of people who are involved in the Diabetes and Endocrinology community, since we have members from all over the world who are interested in learning about Diabetes care, treatment, and its advancements. The conference's characteristics include internationally recognized speakers, the most recent methods, discoveries, and breakthroughs in Health Care, Diabetes, Obesity, Different types of Diabetes, Diabetes problems, Skin Manifestations of Diabetes, Diabetes in Pregnancy, Endocrine Disorders, Diagnosis and Treatment. People are searching for the most innovative treatments for illnesses, diseases, and other ails all across the world.

Your best chance to attend the largest gathering of Medical experts, Diabetologists, and endocrinologists is at the World Diabetes 2024. At this two-day conference, present papers, disseminate information, network with established and upcoming scientists, make a splash with novel discoveries and therapeutic approaches and establish your name in the field.

  • Opportunity to attend the presentations delivered by Eminent Scientists from all over the world
  • Accepted abstracts will be published in the Journal of Endocrinology & Diabetes Research and provided with DOI
  • Discuss your ideas and views with pioneers in the fields of Diabetes, Endocrinology, Obesity, Health Care
  • Be a part of the interactive debates, plenary sessions and discussions about the current issues in the area of Diabetes and come to a consensus using evidence-based expert opinion

 

Track 1: Diabetes and Types of Diabetes

Diabetes is a chronic medical condition that affects how your body processes glucose (sugar), which is the body's primary source of energy. There are two main types of diabetes: Type 1 and Type 2, along with other less common forms like Gestational Diabetes.

Type 1 Diabetes:

Type 1 Diabetes is an autoimmune condition in which the body's immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, people with Type 1 diabetes do not produce insulin, which is essential for regulating blood sugar. It typically develops in childhood or adolescence, and individuals. People with Type 1 diabetes require lifelong insulin therapy to manage their blood sugar levels.

Type 2 Diabetes:

Type 2 Diabetes is a form of diabetes is more common and is often linked to lifestyle factors, including obesity, physical inactivity, and poor diet. In Type 2 diabetes, the body either does not produce enough insulin or becomes resistant to its effects, resulting in elevated blood sugar levels. Initially, it can often be managed with lifestyle changes, including diet and exercise, but medication or insulin may be necessary as the condition progresses.

Here are some factors that may play a role in the development of type 2 diabetes:

  • Genetics
  • Insulin Resistance
  • Obesity
  • Unhealthy Diet
  • Lack of physical activity
  • Other Medical Conditions

Gestational Diabetes (GDM):

Gestational diabetes occurs when your body can't make enough insulin during your pregnancy. Insulin is a hormone made by your pancreas that acts like a key to let blood sugar into the cells in your body for use as energy. This type of diabetes occurs during pregnancy and usually resolves after childbirth. It can, however, increase the risk of both the mother and the child developing Type 2 diabetes later in life.

The common symptoms of Gestational diabetes include:

  • Increased thirst and urination
  • Unexplained weight loss
  • Fatigue
  • Blurred vision
  • Slow-healing wounds
  • Tingling or numbness in the extremities

Long-term, uncontrolled diabetes can lead to serious complications, including heart disease, stroke, kidney disease, vision problems, and nerve damage.

Related Association Societies: American Diabetes Association  | European Association for the Study of Diabetes | International Diabetes Federation | Endocrine Society | Pediatric Endocrine Society | Society for Endocrinology | Canadian Society of Endocrinology and Metabolism | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | Middle East and North Africa Region Diabetes Association

Track 2: Genetic Diabetes

Many individuals throughout the world are still unaware of what genetic diabetes is. This allows people enter pre-diabetic phases without ever realising it, which causes a plethora of problems. Because of hereditary factors that are activated, certain people are predisposed to Diabetic diseases.

Genetic diabetes, also known as monogenic diabetes, is a type of diabetes that is caused by a mutation or change in a single gene. Unlike type 1 or type 2 diabetes, which are complex conditions influenced by multiple genes and environmental factors, monogenic diabetes is primarily driven by a specific genetic mutation. This genetic Diabetes appearance will go through the precautions and treatments that must be taken to avoid inherited Diabetes. If you suspect you or someone you know may have genetic diabetes, it's crucial to consult a healthcare professional for proper evaluation, diagnosis, and management. They can provide specific guidance and treatment options based on the type of genetic diabetes involved.

Related Association Societies: Latin American Diabetes Association (ALAD) | Juvenile Diabetes Research Foundation | Russian Diabetes Federation | Diabetes Canada | Diabetes India | Diabetes UK | African Diabetes Association | Australian Diabetes Society | The Endocrine Society | Pediatric Endocrine Society | American Association of Clinical Endocrinologists

Track 3: Diabetes Symptoms and Complications

Diabetes is a disease in which the body cannot produce enough insulin, cannot use normally produced insulin, the body cannot transport the sugar in the blood to the cells. This can lead to high Blood Sugar Level. Glucose, in the form of sugar in the blood, is one of the main sources of energy. Insulin shortage or insulin resistance can cause sugar to accumulate in the blood. This may cause different health problems those may

  • Extreme hunger
  • Frequent urination
  • Unexplained weight loss
  • Thirsty
  • Blurry Vision
  • Slow Wound Healing

Complications of Diabetes:

  • Cardiovascular disease: Diabetes increases the risk of heart disease, stroke, and other cardiovascular conditions.
  • Kidney disease: Diabetes can lead to kidney damage or failure over time.
  • Eye problems: Diabetes can lead to vision problems, including diabetic retinopathy, cataracts, and glaucoma.
  • Nerve damage (Neuropathy): This can lead to pain, tingling, and loss of sensation in the extremities.
  • Foot problems: Poor blood circulation and nerve damage can lead to foot ulcers and infections.
  • Skin conditions: Diabetes can cause skin problems, including bacterial and fungal infections.
  • Alzheimer's disease: Some studies suggest a link between diabetes and an increased risk of developing Alzheimer's.

It's crucial for individuals with diabetes to manage their condition through proper diet, exercise, medication (if necessary), and regular check-ups with healthcare professionals. Early detection and proper management can significantly reduce the risk of complications.

Related Association Societies: Federation of International Nurses in Endocrinology | Thyroid Federation International | Obesity Canada | Nutrition and Metabolism Society | National Institutes of Health | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | African Diabetes Association | Australian Diabetes Society

Track 4: Diabetes Mellitus: Diagnosis, Management, and Treatment Strategies

Diabetes frequently referred to by specialists as diabetes mellitus is a chronic disease characterized by high blood sugar levels, and it can lead to serious health complications if left uncontrolled. Diabetes Diagnosis, management and prevention are crucial to reducing the impact of diabetes on individuals and society. Patients with high glucose will normally encounter polyuria (continuous pee); they will turn out to be progressively parched (polydipsia) and hungry (polyphagia). Recognizing type 1 and type 2 diabetes at determination is critical. Prevention of diabetes involves making lifestyle changes to reduce the risk of developing type 2 diabetes, which is the most common form of diabetes. This includes maintaining a healthy weight, engaging in regular physical activity, and eating a healthy diet. Other risk factors for diabetes include family history, age, and ethnicity, which cannot be modified.

  • Recognizing type 1 and type 2 diabetes: similarities and differences
  • Possibly, diabetes medication or insulin therapy
  • Foot care
  • Advances in diabetes treatment: Surgeries, lifestyle changes, and technology
  • Diabetes prevention programs and public health initiatives

Related Association Societies: American Diabetes Association  | European Association for the Study of Diabetes | International Diabetes Federation | Endocrine Society | Pediatric Endocrine Society | Society for Endocrinology | Canadian Society of Endocrinology and Metabolism | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | Middle East and North Africa Region Diabetes Association

Track 5: Anti-Diabetes Drugs

There are several types of anti-diabetes drugs available to help manage blood sugar levels in individuals with diabetes. Except for insulin, liraglitude, exenatide and pramlinitide they all are administered orally, so they are also called oral hypoglycaemic agents. These drugs work in various ways to increase insulin production, decrease glucose production in the liver, improve insulin sensitivity, or slow down the absorption of glucose from the digestive tract. There are different types of Anti-Diabetic Drugs, and their choice depends on the nature of diabetes, the person’s age and condition, and other factors. Type 1 diabetes is a disease caused by insufficient insulin. Insulin must be used for type 1 must be injected.

Here are some common classes of anti-diabetes drugs:

  • Metformin
  • Sulfonylureas
  • Meglitinides
  • Thiazolidinediones (TZDs)
  • Alpha-glucosidase inhibitors and many more

Additionally, lifestyle changes like a healthy diet and regular exercise are often crucial components of managing diabetes.

Related Association Societies: Latin American Diabetes Association (ALAD) | Juvenile Diabetes Research Foundation | Russian Diabetes Federation | Diabetes Canada | Diabetes India | Diabetes UK | African Diabetes Association | Australian Diabetes Society | The Endocrine Society | Pediatric Endocrine Society | American Association of Clinical Endocrinologists

Track 6: Insulin Therapy and Advances in Insulin Delivery Systems

Insulin is injected into diabetics who cannot control their condition with oral medications. Insulin therapy is a crucial treatment for people with diabetes. It involves directing insulin, a hormone that helps regulate blood sugar levels, either through injections or an insulin pump. The goal of insulin therapy is to mimic the body's natural insulin production and maintain blood sugar levels within a target range. Doing exercise daily may shorten insulin requirements as exercise boost up glucose uptake by body cells whose glucose uptake is composed by insulin and vice versa. Moreover, there are different types of insulin with differing times of onset and period of action.

Advances in Insulin Delivery Systems are:

  • Glucose-responsive automated insulin delivery
  • Continuous Glucose Monitoring (CGM) and Insulin Pumps Integration
  • Closed-Loop Systems (Artificial Pancreas)
  • Smart Insulin Pens
  • Inhaled Insulin
  • Ultra-Rapid-Acting Insulin and many more

Related Association Societies: American Diabetes Association  | European Association for the Study of Diabetes | International Diabetes Federation | Endocrine Society | Pediatric Endocrine Society | Society for Endocrinology | Canadian Society of Endocrinology and Metabolism | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | Middle East and North Africa Region Diabetes Association

Track 7: Diabetic Neuropathy and Diabetic Nephropathy

Diabetic Neuropathy is a type of nerve damage that can occur in people with diabetes. It is a common complication of both type 1 and type 2 diabetes. High blood sugar levels over an extended period of time can lead to damage of the nerves throughout the body. Prevention and management of diabetic neuropathy involves maintaining good blood sugar control, regular exercise, and a healthy lifestyle. Medications may also be prescribed to manage symptoms and slow down the progression of the condition. Regular check-ups with a healthcare provider are crucial for individuals with diabetes to monitor for signs of neuropathy and other potential complications.

  • Peripheral neuropathy
  • Autonomic neuropathy
  • Proximal neuropathy
  • Focal neuropathy

Diabetic Nephropathy, also known as diabetic kidney disease, is a serious complication of diabetes that affects the kidneys. It is a leading cause of kidney failure worldwide. This condition develops in individuals with both type 1 and type 2 diabetes, but it is more common in those with poorly controlled blood sugar levels over an extended period. Regular check-ups with a healthcare provider are crucial for individuals with diabetes to monitor for signs of nephropathy and other potential complications.

  • Dialysis
  • Chronic Kidney disease and Management
  • Nephrology and Therapeutics
  • Glomerular Hyperfiltration

Related Association Societies: Federation of International Nurses in Endocrinology | Thyroid Federation International | Obesity Canada | Nutrition and Metabolism Society | National Institutes of Health | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | African Diabetes Association | Australian Diabetes Society

Track 8: Skin Manifestations of Diabetes

Diabetes is a common and debilitating disease that affects many organs including the skin. Between 30% and 70% of people with type 1 and type 2 Diabetes will develop diabetic skin complications at some stage in their lives. Various manifestations of skin diseases are related to diabetes. The severity of these conditions varies, and they may be benign, disfigured, or even life-threatening. These skin changes can provide information about the patient's blood sugar control and may be the first sign of metabolic disorders in undiagnosed diabetic patients.

Some common skin conditions in diabetic patients are:

  • Diabetes food syndrome
  • Limited joint mobility
  • Acanthosis nigricans
  • Diabetes thick skin

Related Association Societies: Latin American Diabetes Association (ALAD) | Juvenile Diabetes Research Foundation | Russian Diabetes Federation | Diabetes Canada | Diabetes India | Diabetes UK | African Diabetes Association | Australian Diabetes Society | The Endocrine Society | Pediatric Endocrine Society | American Association of Clinical Endocrinologists

Track 9: Cardiovascular Risk in Type 2 Diabetes

Cardiovascular disease (CVD) is a major complication of diabetes and a leading cause of morbidity and mortality worldwide. Diabetes mellitus is a chronic condition that occurs either the body cannot produce enough or produced insulin that the body does not use properly. Comparisons of people without diabetes, people with type 2 diabetes mellitus have a considerably higher risk of cardiovascular morbidity and mortality and are excessively affected by cardiovascular disease. Most of this excess risk is associated with better prevalence of well-known risk factors such as hypertension, dyslipidemia and obesity. For medication, such as statins and blood pressure-lowering agents, may be necessary for some individuals. Recent advances in personalized medicine and Regular approaches of healthcare providers are crucial for effective management and prevention of CVD.

  • Hypertension
  • Dyslipidemia
  • Obesity
  • Insulin resistance and Hyperglycemia
  • Microvascular complications

Related Association Societies: American Diabetes Association  | European Association for the Study of Diabetes | International Diabetes Federation | Endocrine Society | Pediatric Endocrine Society | Society for Endocrinology | Canadian Society of Endocrinology and Metabolism | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | Middle East and North Africa Region Diabetes Association

Track 10: Diabetic Nutrition and Physical Fitness

Diabetic nutrition and exercise are two critical components of managing diabetes effectively. Proper nutrition and regular physical activity can help control blood sugar levels, reduce the risk of complications, and improve overall health and well-being. By adopting healthy eating habits and engaging in regular physical activity, individuals with diabetes can control their blood sugar levels, reduce the risk of complications, and improve their overall health and well-being.

In addition, experts also recommend resistance and strength exercise at least twice a week. Use sport to fight diabetes. If you have type 1 diabetes or type 2 diabetes, take action! Physical activity: increase your heart rate. Exercise also allows blood to flow to all organs, especially the brain, eyes, and kidneys. Reduce stress, stress increase the risk of diabetes. Moreover, for diabetic patients, stress makes it difficult for them to control their conditions.

  • Balanced Diet
  • Stay Hydrated
  • Exercise and physical activity
  • Listen to Your Body
  • Be prepared to adjust your insulin or medication dosage

Related Association Societies: Federation of International Nurses in Endocrinology | Thyroid Federation International | Obesity Canada | Nutrition and Metabolism Society | National Institutes of Health | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | African Diabetes Association | Australian Diabetes Society

Track 11: Diabetes in Pregnancy (Gestational Diabetes Mellitus (GDM))

Diabetes can have significant effects on pregnancy, both for the mother and the developing baby. Two types of diabetes can affect pregnancy: pre-existing diabetes and gestational diabetes. Gestational diabetes mellitus (GDM) is a type of diabetes that develops during pregnancy. It is characterized by high blood sugar levels that occur for the first time during pregnancy and usually resolves after giving birth. GDM can develop in women who have never had diabetes before, and it is believed to be related to the hormonal changes and increased insulin resistance that occur during pregnancy.

Women with diabetes can have healthy pregnancies and deliver healthy babies. It is important for women with diabetes who are planning to become pregnant to work closely with their healthcare team to optimize their diabetes management before and during pregnancy and need to test for changes in blood sugar levels more frequently to manage Gestational diabetes and preventing complications such as macrosomia and neonatal hypoglycemia.

  • A lack of physical activity
  • If a woman's close family members have diabetes
  • Previously delivering a baby weighing more than 9 pounds
  • Overweight or Obesity

Related Association Societies: Latin American Diabetes Association (ALAD) | Juvenile Diabetes Research Foundation | Russian Diabetes Federation | Diabetes Canada | Diabetes India | Diabetes UK | African Diabetes Association | Australian Diabetes Society | The Endocrine Society | Pediatric Endocrine Society | American Association of Clinical Endocrinologists

Track 12: Stem Cell Treatment in Diabetes

Stem cell treatment in diabetes refers to the use of stem cells to help manage or potentially cure diabetes mellitus. Stem cells are undifferentiated cells with the unique ability to differentiate into specialized cell types. They can be derived from various sources, including embryos (embryonic stem cells), adult tissues (adult or somatic stem cells), and induced pluripotent stem cells (cells that have been reprogrammed to have pluripotent properties).

In the subject of diabetes, stem cell treatment aims to harness the regenerative potential of stem cells to replace or repair damaged or dysfunctional pancreatic cells, which are responsible for producing insulin.

  • Somatic cell Therapy
  • Type 1 Diabetes Beta Cells
  • Cord blood stem cells
  • Stem Cell Educator
  • Thymic regulatory T cells

Related Association Societies: American Diabetes Association  | European Association for the Study of Diabetes | International Diabetes Federation | Endocrine Society | Pediatric Endocrine Society | Society for Endocrinology | Canadian Society of Endocrinology and Metabolism | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | Middle East and North Africa Region Diabetes Association

Track 13: Endocrine Disorders

Endocrine disorders refer to conditions that affect the endocrine system, which is responsible for producing and regulating hormones in the body. Hormones are chemical messengers that play a crucial role in controlling various bodily functions. When the endocrine system malfunctions, it can lead to an imbalance in hormone levels, causing a wide range of health disorders. These disorders can affect many aspects of a person's health, including growth and development, metabolism, reproductive function, and mood.

Some of the Endocrine disorders include:

  • Hypothyroidism
  • Hyperthyroidism
  • Diabetes Mellitus
  • Polycystic Ovary Syndrome (PCOS)
  • Thyroid Cancer
  • Hypopituitarism and many more

Related Association Societies: Federation of International Nurses in Endocrinology | Thyroid Federation International | Obesity Canada | Nutrition and Metabolism Society | National Institutes of Health | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | African Diabetes Association | Australian Diabetes Society

Track 14: Endocrinology and Hormonal Disorders: Diagnosis and Treatment

Endocrinology is the branch of medicine that deals with the endocrine system, which is a network of glands that secrete hormones into the bloodstream to regulate various bodily functions. Hormones play a crucial role in maintaining homeostasis and controlling processes such as metabolism, growth, reproduction, and stress response.

Diagnosing and treating hormonal disorders involves a combination of medical history review, physical examination, laboratory tests, and sometimes imaging studies.

Patient Evaluation and Assessment: Patient evaluation and assessment involve thorough clinical examinations and diagnostic tests to diagnose and monitor endocrine conditions.

Hormone Replacement Therapy: Hormone replacement therapy replaces deficient hormones with synthetic or natural hormones to restore hormonal balance in endocrine disorders.

Surgical Interventions in Endocrinology: Surgical interventions encompass procedures performed to treat endocrine disorders, often involving the removal of affected glands or tumors.

Multidisciplinary Approaches: Multidisciplinary approaches involve collaboration among healthcare professionals from different specialties to provide comprehensive care for endocrine disorders.

Related Association Societies: Latin American Diabetes Association (ALAD) | Juvenile Diabetes Research Foundation | Russian Diabetes Federation | Diabetes Canada | Diabetes India | Diabetes UK | African Diabetes Association | Australian Diabetes Society | The Endocrine Society | Pediatric Endocrine Society | American Association of Clinical Endocrinologists

Track 15: Endocrine Oncology

Endocrine oncology is the speciality of medicine that focuses on the diagnosis and treatment of tumors or cancers that arise from the endocrine system. The endocrine system is a network of glands that produce and secrete hormones, which are chemical messengers that regulate various physiological processes in the body. Common endocrine glands include the pituitary gland, thyroid gland, parathyroid glands, adrenal glands, pancreas, ovaries, and testes. Tumors can develop in any of these glands, and they can be benign (non-cancerous) or malignant (cancerous).

Mainly Endocrine oncology deals with tumours caused by thyroid hormones, often known as endocrine neoplasia. There are two types of endocrine neoplasia; both are genetic abnormalities that can be passed down from generation to generation. The first kind is called as warmers disorder, while the second type is known as pheochromocytoma or straightforward condition, both of which resulted in medullary thyroid cancer.

  • Adrenal gland tumors
  • Multiple endocrine neoplasias 1 (MEN1)
  • Multiple endocrine neoplasias 2 (MEN 2)
  • Parathyroid gland tumors
  • Pituitary gland tumors
  • Pancreatic cancer
  • Thyroid cancer

Related Association Societies: American Diabetes Association  | European Association for the Study of Diabetes | International Diabetes Federation | Endocrine Society | Pediatric Endocrine Society | Society for Endocrinology | Canadian Society of Endocrinology and Metabolism | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | Middle East and North Africa Region Diabetes Association

Track 16: Pediatric Endocrinology

Pediatric Endocrinology is a specialized branch of medicine that deals with disorders of the endocrine glands in children. The endocrine system is responsible for producing hormones, which regulate various functions in the body. Pediatric endocrinologists are medical doctors who have received specialized training to diagnose, treat, and manage conditions related to hormone imbalances in children and adolescents. Treatment in pediatric endocrinology often involves a combination of medication, hormone replacement therapy, dietary modifications, and in some cases, surgery. Pediatric endocrinologists work closely with other specialists, such as pediatric surgeons, geneticists, and nutritionists, to provide comprehensive care for their patients.

  • Type 1 and Type 2 Diabetes
  • Growth disorders
  • Thyroid disorders
  • Puberty disorders
  • Adrenal and Pituitary disorders
  • Bone and Mineral disorders
  • Metabolic disorders and Endocrine tumors

Related Association Societies: Federation of International Nurses in Endocrinology | Thyroid Federation International | Obesity Canada | Nutrition and Metabolism Society | National Institutes of Health | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | African Diabetes Association | Australian Diabetes Society

Track 17: Pituitary and Neuroendocrinology

Neuroendocrinology is the branch of biology that studies the interactions between the nervous system and the endocrine system. The nervous system and the endocrine system are two major regulatory systems in the body, and they work together to coordinate various physiological processes. It has wide-ranging implications for both basic science and clinical medicine.

Pituitary Endocrinology refers to the study of the pituitary gland and its role in the endocrine system. The pituitary gland, also known as the hypophysis, is a small, pea-sized gland located at the base of the brain, just below the hypothalamus. Despite its small size, the pituitary gland plays a crucial role in regulating various bodily functions by secreting hormones. Treatment for pituitary disorders may involve medication, surgery (in the case of tumors), and hormone replacement therapy. Regular monitoring and management by endocrinologists or other healthcare professionals with expertise in pituitary disorders are crucial for individuals with these conditions.

Disorders related to Pituitary endocrinology include:

  • Hypopituitarism
  • Hyperpituitarism
  • Pituitary Tumors
  • Diabetes Insipidus

Related Association Societies: American Diabetes Association  | European Association for the Study of Diabetes | International Diabetes Federation | Endocrine Society | Pediatric Endocrine Society | Society for Endocrinology | Canadian Society of Endocrinology and Metabolism | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | Middle East and North Africa Region Diabetes Association

Track 18: Thyroid Disorders: Diagnosis, Treatment

Thyroid disorders are the common endocrine conditions that affect the thyroid gland, a small butterfly-shaped gland located in the front of your neck. This gland produces hormones that regulate various bodily functions, including metabolism. There are several types of thyroid disorders, with the most common being. Thyroid disorders can arise due to various factors, and they can be influenced by a combination of genetic, environmental, and lifestyle elements. Current trends in thyroid disorder management focus on personalized treatment plans based on patient characteristics and disease severity. Diagnosis often involves blood tests and imaging studies, followed by appropriate management strategies, including medication, surgery, and radioactive iodine therapy. Recent advances in thyroid disorder management include the use of targeted therapy and immunotherapy for thyroid cancer. Additionally, thyroid hormone replacement therapy has been shown to improve outcomes for patients with hypothyroidism.

There are several types of thyroid disorders, including:

  • Hypothyroidism
  • Hyperthyroidism
  • Goiter
  • Thyroid Nodules
  • Thyroiditis and Thyroid Cancer
  • Congenital Thyroid Disorders

Related Association Societies: Latin American Diabetes Association (ALAD) | Juvenile Diabetes Research Foundation | Russian Diabetes Federation | Diabetes Canada | Diabetes India | Diabetes UK | African Diabetes Association | Australian Diabetes Society | The Endocrine Society | Pediatric Endocrine Society | American Association of Clinical Endocrinologists

Track 19: Obesity and Diabetes

Obesity is regularly caused by an underlying condition characterised by excessive body fat build-up. It has a major negative impact on health, especially by raising the risk of other chronic illnesses such as heart disease and diabetes. Obesity is defined as a BMI (Body Mass Index) of more than 30 kg/m2. Obesity is one of the most prevalent disorders in developed nations, and its prevalence is rising.

Obesity increases the risk of developing type 2 diabetes, also known as insulin-resistant diabetes or adult-onset diabetes. This is when your blood glucose level remains elevated over a lengthy period of time. According to a study, obese people are up to 80 times more likely than non-obese people to get type 2 diabetes. Managing obesity through a combination of a balanced diet, regular physical activity, and, in some cases, medical intervention can help improve insulin sensitivity and reduce the risk of developing type 2 diabetes. Additionally, early detection and appropriate management of diabetes can help prevent complications associated with the condition.

There are several ways in which obesity can contribute to the development of diabetes:

  • Insulin
  • Inflammation and Cytokines
  • Dyslipidemia
  • Beta Cell Dysfunction
  • Influence on Hormones
  • Ectopic Fat Accumulation
  • Lifestyle Factors

Related Association Societies: Federation of International Nurses in Endocrinology | Thyroid Federation International | Obesity Canada | Nutrition and Metabolism Society | National Institutes of Health | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | African Diabetes Association | Australian Diabetes Society

Track 20: Obesity and Metabolic Syndrome: Prevention and Treatment

Obesity is a major risk factor for developing metabolic syndrome. Excessive body fat, particularly around the abdomen, is strongly associated with insulin resistance and other components of metabolic syndrome.

Metabolic syndrome is a significant risk factor for cardiovascular diseases like heart attacks and strokes, as well as type 2 diabetes. It is also associated with other health issues, including fatty liver disease and sleep apnea.

Lifestyle changes, such as maintaining a healthy weight, regular physical activity, and a balanced diet, can help manage and reduce the risk of metabolic syndrome. In some cases, medications may be prescribed to control specific risk factors. Additionally, medication and surgery may be appropriate for some individuals. In recent years, personalized medicine and precision health approaches have emerged as potential avenues for the prevention and treatment of obesity and metabolic syndrome.

Related Association Societies: Latin American Diabetes Association (ALAD) | Juvenile Diabetes Research Foundation | Russian Diabetes Federation | Diabetes Canada | Diabetes India | Diabetes UK | African Diabetes Association | Australian Diabetes Society | The Endocrine Society | Pediatric Endocrine Society | American Association of Clinical Endocrinologists

Track 21: Diabetes and Mental Health

Diabetes and mental health are closely interconnected, with diabetes increasing the risk of mental health conditions such as depression and anxiety, and poor mental health worsening diabetes management challenges. The fear of blood sugar fluctuations can be very stressful. Changes in blood sugar can cause rapid changes in mood and other mental symptoms such as fatigue, trouble thinking clearly, and anxiety. Managing diabetes not only involves monitoring blood sugar levels and taking medications but also addressing the emotional and psychological aspects of the condition. Additionally, lifestyle modifications, such as regular physical activity and stress reduction, can improve both physical and mental health outcomes. Addressing the mental health implications of diabetes is crucial for providing comprehensive care and improving health.

  • Patient Education and Self-Management
  • Screening for Mental Health Conditions
  • Open Communication
  • Medication Management
  • Nutrition and Exercise
  • Family and Social Support

Related Association Societies: American Diabetes Association  | European Association for the Study of Diabetes | International Diabetes Federation | Endocrine Society | Pediatric Endocrine Society | Society for Endocrinology | Canadian Society of Endocrinology and Metabolism | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | Middle East and North Africa Region Diabetes Association

Track 22: The Role of Steroids and Hormones and Receptors in Diabetes and Endocrine Disorders

Steroids, hormones, and their respective receptors play crucial role in the development and management of diabetes and Endocrine Disorders. Diabetes is a metabolic disorder characterized by high blood sugar levels, either due to insufficient insulin production (Type 1 diabetes) or ineffective use of insulin by the body (Type 2 diabetes).

Some of the steroids, hormones, and their receptors are involved in diabetes:

  • Insulin
  • Glucagon
  • Hormone Receptors
  • Glucocorticoids (Steroids)
  • Corticosteroids steroid and Diabetes Risk

Related Association Societies: Federation of International Nurses in Endocrinology | Thyroid Federation International | Obesity Canada | Nutrition and Metabolism Society | National Institutes of Health | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | African Diabetes Association | Australian Diabetes Society

Track 23: Diabetes Research and Clinical Practice

Diabetes research is a broad and continuously evolving field that focuses on understanding, preventing, managing, and ultimately finding a cure for diabetes. Clinical trials related to diabetes are essential for advancing our understanding of the condition and developing new treatments. It includes basic laboratory research, clinical trials, epidemiological studies, and translational research.

There are several important topics of research within the field of diabetes:

  • Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D)
  • Gestational Diabetes
  • Complications
  • Technological Advances
  • Genetics and Epigenetics
  • Immunotherapy
  • Regenerative Medicine
  • Behavioral Interventions
  • Global Health and Access to Care
  • Artificial Intelligence and Data Analytics

It's important to note that progress in diabetes research and clinical trials are ongoing, and new discoveries and breakthroughs continue to emerge. Researchers and healthcare professionals around the world work tirelessly to improve the lives of individuals affected by diabetes.

Related Association Societies: Latin American Diabetes Association (ALAD) | Juvenile Diabetes Research Foundation | Russian Diabetes Federation | Diabetes Canada | Diabetes India | Diabetes UK | African Diabetes Association | Australian Diabetes Society | The Endocrine Society | Pediatric Endocrine Society | American Association of Clinical Endocrinologists

Track 24: Advanced Technologies and Treatments for Diabetes

Advanced technologies are revolutionizing diabetes and endocrine disorders monitoring and treatment, providing individuals with more accurate and personalized care. Continuous glucose monitoring (CGM) systems offer real-time tracking of blood glucose levels, reducing the risk of hypoglycemia and hyperglycemia. Smart insulin pens and connected devices provide easy tracking of insulin doses and blood glucose levels through mobile applications, improving medication adherence and disease management. Additionally, closed-loop insulin delivery systems, also known as artificial pancreas systems, offer automated insulin dosing based on CGM readings, reducing the burden of diabetes management for individuals. These new technologies provide individuals with more control over their diabetes management and can lead to improved health outcomes. Regular monitoring and communication with healthcare providers remain important for effective use of these new technologies.

  • Continuous glucose monitoring (CGM)
  • Insulin Pumps and Smart Insulin Pens
  • Artificial Pancreas (Closed-Loop System)
  • Gene Therapy
  • Closed-Loop Apps for Smartphones and many more

Related Association Societies: American Diabetes Association  | European Association for the Study of Diabetes | International Diabetes Federation | Endocrine Society | Pediatric Endocrine Society | Society for Endocrinology | Canadian Society of Endocrinology and Metabolism | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | Middle East and North Africa Region Diabetes Association

Track 25: Self-Management Education and Support for Diabetes Patients

Diabetes education and self-management are crucial for empowering individuals with diabetes to take an active role in their care and improve their health outcomes. Diabetes education programs can provide information on blood glucose monitoring, medication management, healthy eating habits, and physical activity, as well as offer support for emotional well-being. Self-management techniques such as goal setting, problem solving, and stress management can help individuals with diabetes to successfully manage their condition and prevent complications. Additionally, peer support groups and community resources can provide further support and motivation for individuals with diabetes. By emphasizing education and self-management, healthcare providers can empower patients to take control of their health and achieve better results.

Related Association Societies: Federation of International Nurses in Endocrinology | Thyroid Federation International | Obesity Canada | Nutrition and Metabolism Society | National Institutes of Health | Asian Association for the Study of Diabetes | American Association of Clinical Endocrinologists | African Diabetes Association | Australian Diabetes Society

Track 26: Telemedicine and Diabetes Care

Telemedicine refers to the remote delivery of healthcare services using technology, typically through video calls, phone consultations, and secure messaging platforms. Telemedicine has emerged as a valuable tool for diabetes care, offering opportunities to improve access to care, patient engagement, and clinical results. Telemedicine can facilitate remote monitoring of blood glucose levels, medication adherence, and lifestyle behaviours as well as provide virtual consultations with healthcare providers. However, challenges remain in ensuring equitable access to telemedicine services, addressing privacy and security concerns, and ensuring the accuracy and reliability of remote monitoring devices. Additionally, telemedicine should be integrated into a comprehensive diabetes care plan and not be seen as a substitute for in-person care when necessary. Addressing these challenges will be crucial for realizing the full potential of telemedicine in diabetes care

Additionally, patient education and training on how to effectively use telemedicine tools are crucial to ensure its successful implementation in diabetes care. Overall, the integration of telemedicine into diabetes care has the potential to significantly improve results and the overall quality of life for individuals living with diabetes. It offers a more patient-centric approach by providing convenient, accessible, and personalized care.

Related Association Societies: Latin American Diabetes Association (ALAD) | Juvenile Diabetes Research Foundation | Russian Diabetes Federation | Diabetes Canada | Diabetes India | Diabetes UK | African Diabetes Association | Australian Diabetes Society | The Endocrine Society | Pediatric Endocrine Society | American Association of Clinical Endocrinologists

The global diabetes devices market size was valued at USD 28.1 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2030. The market is primarily driven by factors such as an increase in technological advancements and rise in the incidences of obesity. Moreover, increasing adoption of insulin delivery devices and rising prevalence of diabetes are driving market growth. Leading manufacturers are focusing on technological innovations and development of advanced products to gain substantial share of the market.

More than 100 million American adults now have diabetes, according to a new report from the Centres for Disease Control and Prevention (CDC). The number of diabetics increased from 108 million in 1980 to 422 million in 2018. This is the fastest growing in low-income countries. Diabetes is the leading cause of vision problems, heart attacks, kidney failure and stroke. In 2019, another 2.2 million people died of hyperglycaemia. Almost half of all deaths from hyperglycaemia occur before the age of 70. Does WHO estimate that diabetes will be the seventh leading cause of death in 2025? The popularity of diabetes in all age groups around the world is projected to be 3% for 3,000 people and 5.2% for 2,080 people.

Individuals diagnosed with diabetes are at an increased risk for COVID-19, thereby accelerating the demand of diabetes devices to effectively manage patients in hospital as well as home care settings. The increasing demand of diabetes devices is attributed to preventing the longer hospital stays and higher mortality rates in diabetic patients.

Increase in incidence of diabetes due to aging, obesity, and unhealthy lifestyle is one of the factors contributing to the growth of the market. Obesity is a major factor leading to diabetes. According to World Health Organization (WHO), in 2016, over 1.9 billion adults were overweight, of which, around 650 million people were obese. Risk factors, such as obesity and overweight, are leading to an increase in the incidence of diabetes. Therefore, risk factors such as smoking, overweight, obesity, and high cholesterol levels are expected to boost the prevalence of diabetes, thus fueling the need for diabetes devices.

Insulin delivery devices are identified as the fastest growing segment in the global diabetes devices market and account for over 54.0% share in 2022. The insulin delivery devices are further analyzed for pens, pumps, syringes and jet injectors. Pens held a larger share of the diabetes devices market in 2022. However, the pump segment is expected to gain substantial market share as it is estimated to grow at the fastest CAGR during the forecast period.

The adoption of blood glucose meters is gradually increasing due to advantages such as portability and accuracy. Market players are also focusing on developing these devics and are introducing small blood glucose meters. The introduction of these small, discreet, and easy-to-use blood glucose meters is expected to boost segment growth during the forecast years.

 

Types of participation

World Diabetes 2024, provides the participants with different modes or ways to participate under either Academic / Student / Business Category

  1. Keynote speaker: 45-50 minutes
  2. Speaker (oral presentation): 25-30 minutes (only one person can present)
  3. Speaker (workshop): 45-50 minutes (more than 1 can present)
  4. Speaker (special session): 45-50 minutes (more than 1 can present)
  5. Speaker (symposium): more than 45 minutes (more than 1 can present)
  6. Delegate (only registration): will have access to all the sessions with all the benefits of registration
  7. Poster presenter:  can present a poster and enjoy the benefits of delegate
  8. Remote attendance:  can participate via virtual mode or video presentation or e-poster presentation
  9. Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes
  10. Media Partner
  11. Sponsor
  12. Collaborator

Advantages of Participating in our Conference

  • Attendees will be certified with CPD credits with participation certification
  • The Speaker and Abstract pages that Google creates on your profile under your name would give you global visibility.
  • Our Library of Abstracts receives more than 30,000 visits per month and 50 thousand views, which brings scholars and speakers to our Conference.
  • Interactive meetings will be provided, if you are coming with your research squad
  • Meet and exchange ideas with many of thought leaders in the Diabetes and Endocrinology field
  • Young scientist award & Best Poster certificates
  • Each conference attendee would have a different motivation for engaging in one-on-one discussions with distinguished speakers and recognized keynote speakers.
  • At our Keynote presentations, you'll have the exceptional chance to hear what the world's foremost authorities on Diabetes are discovering.

Benefits of Participation for Speaker

  • All accepted abstracts will be published in the respective Journals
  • Attendees will be certified with CPD credits with participation certification
  • Admiration for researchers' profiles on a global scale.
  • Obtain points for your professional development.
  • Discover the most recent cutting-edge analysis.
  • Become lifelong friends through social and networking activities.
  • An opportunity to promote one page through the distribution of abstract books and flyers, which eventually receive 1 million views and greatly enhance your research profile.
  • Learn about new topics and studies that are unrelated to your primary subject of Diabetes and Endocrinology field by making a transition outside of your field of interest.
  • We've combined exceptional networking, education, and fun into one bundle.

Benefits of Participation for Delegate

  • Increased knowledge and understanding for professional development.
  • Attending webinars helps participants feel refreshed and energized.
  • Your participation in our conference will support the development of a new approach and philosophy that can be used to improve business or industry results.
  • Opportunities for Diabetes and Endocrinology field scholars and practitioners to connect and share new perspectives at our conference.

Benefits of Participation for Sponsor

  • The likelihood of new businesses would rise with exposure to the global marketplace.
  • A chance to showcase your business's most cutting-edge innovations, fresh products, or services to a large international audience.
  • Lead generation will help our webinar participants do more business.
  • To draw energy from others who have a similar purpose and objective, it's always helpful to have a network of co-workers and associates. Building a successful firm takes a lot of time, effort, and drive.
  • Webinars on Diabetes offer chances for greater thought and reflection, which might help you advance your business.
  • Comparing the major organization's plans and advancing them.
  • Get answers to your company's queries and difficulties at our conference from reliable people.

Benefits of Participation for Collaborators

  • No other website has this many visits, making Diabetes the finest platform for bringing attention to society.
  • Establishing enduring peer ties.
  • Your organization's logo, branding and marketing materials, promotional content, and the webinar banner will all work together to add 40% more subscribers and members to your list.
  • Your association will be greatly impacted by the visibility of our event to your company's placement in the Global Business forum.
  • Your representatives can interact with important delegates to update their knowledge and comprehension of your organization and services.
  • Information will be incorporated into Diabetes advertising materials such as posters, brochures, pamphlets, and services that will be distributed to hospitals, universities, the general public, and researchers.

Early Bird registration: 19 June, 2024

Abstract Submission deadline: 20 October, 2024

Final registration: 24 October, 2024

Kindly register here: https://worlddiabetes.conferenceseries.com/registration.php

Group registration (Minimum 5 members) can avail 20% waivers from the registration fee.

If you have any queries regarding registration process kindly email the  Program Manager at worlddiabetes@alliedmeetings.com or Whatsapp  +44 7418315515 with details of the participant.

                                                                Thanks and Regards,
                                               Ms. Elina Williams | Program Manager
                                                                World Diabetes 2024

                                                     worlddiabetes@alliedmeetings.com
                                                           WhatsApp: +44 7418315515

Planning a trip to London, UK?? Attend our Meeting!!

Issue with VISA??

To support the participants in his/her VISA application process, we issue each participant with VISA support documents. The documents are as follows,

  • The official letter of INVITATION
  • The official letter of the abstract acceptance
  • The receipt of the payment

Points to be noted:

  • Visa  Letter (the official letter of invitation) will be issued only after you have successfully registered and paid for your conference
  • Visa Letters can be issued only for the person accepted to attend the conference.

Please contact the Program Manager, Ms. Elina Williams via diabetes@theresearchpub.com to arrange for a Visa Letter.

Kindly provide us with the following to provide you with VISA LETTERS

  • Your name as appears on your passport
  •  Your Passport Scan Copy
  •  And Abstract Acceptance letter for Presenters

One can make the payment through the following Payment Methods:

  • Payment Gateway/Stripe
  • Bank to Bank transfer

Having trouble in registration?

Please contact Ms. Elina Williams via worlddiabetes@alliedmeetings.com or Whatsapp +44 7418315515. The team of World Diabetes 2024 will provide you the INVOICE for the requested price with which he/she can make the Bank-to-Bank transfer.

World Diabetes 2023

The “25th World Congress on Diabetes and Endocrine Disorders” conference was organized by the Conference Series on August 11, 2023, as a Webinar. The conference was based on the Theme: “Exploring the new technologies in the field of Diabetes and Endocrinology,” which was very well received by the audience, and they featured eminent keynote speakers from several prominent organizations and universities. Young and accomplished researchers, business representatives, and outstanding student communities from many parts of the world attended the conference, which helped it become a success.

This World Diabetes 2023 highlights several times on studies relating to Diabetic disorders. The occasion solidified a link between prospective Diabetic and Endocrinology plans and the scientific community. The exchange of applicable and abstract data will encourage organizational partnerships that will accelerate science.

On behalf of our Organizing Committee, we would like to extend our appreciation for the continued support and active participation of the Organizing Committee Member, Keynote Speakers and our Moderators for the successful completion of the World Diabetes 2023. With your help, we'd want to put together this conference to bring together researchers and experts in Diabetes and Endocrinology on one single stage. We truly hope to be allowed to organize this event on a huge scale with your support.

In the last, we would also like to extend my ward regards to various delegate experts, Company representatives, and eminent personalities who supported the conference by facilitating active discussion forums. We would like to convey our sincere gratitude to all the supporters from Editorial Board Members of our Open Access Journals, Keynote Speakers, Honourable guests, Valuable Speakers, Students, delegates, and special thanks to Media Partners for their promotions for making this event a successful one.

Save the dates for the most awaited occasion in 2024.

Based on the positive response and feedback we received from participants and supporters at World Diabetes 2023, we are proud to announce our upcoming conferences in the Series “26th World Congress on Diabetes and Endocrine Disorders,” held on October 24-25, 2024 | London, UK with the theme Recent advancements and complications in the field of diabetes and Endocrinology.

Let us meet again @World Diabetes 2024

Once again, it is a pleasure to extend a warm welcome to all of you at the upcoming 26th World Congress on Diabetes and Endocrine Disorders,'' which will take place in London, UK, from October 24-25, 2024.

Join our team World Diabetes 2024 and let's make this business meeting a tremendous success in the beautiful city of London, UK.

Visit: Diabetes Conference 2024 for further details and to register.

                                                                           Contact us:
                                                    Ms. Elina Williams | Program Manager
                                                                 World Diabetes 2024
                                                           worlddiabetes@alliedmeetings.com
                                                               WhatsApp: +44 7418315515

 

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 24-25, 2024
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View